Summit Therapeutics Inc (SMMT) - News Archive

Showing 2 of 22 results.

Summit Therapeutics Inc. Reports Promising Progress and Strong Financial Results, Aims for Revolutionary Biopharmaceutical Breakthrough

Summit Therapeutics Reports Strong Financial Results and Promising Operational Progress for Q3 and Nine Months Ended September 30, 2023Summit Therapeutics Inc. (NASDAQ: SMMT) has announced its financial results and prov...

Nov 7, 2023 Business Update NASDAQ

Empowering the Immune System: Ivonescimab's Cooperative Binding Unleashes the Potential of Cancer Immunotherapy

In a major breakthrough for cancer immunotherapy, Summit Therapeutics Inc. (NASDAQ: SMMT) has unveiled groundbreaking data on its potential first-in-class investigational bispecific antibody, ivonescimab. The eagerly aw...

Oct 31, 2023 Stock Transactions NASDAQ